{"id":"W2275948481","doi":"10.1182/blood-2004-03-0796","title":"Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":407,"is_retracted":false,"has_abstract":true,"ca_institutions":"Kingston General Hospital","funders":"State University of New York Upstate Medical University; University of North Carolina at Chapel Hill; University of Illinois at Urbana-Champaign; Virginia Commonwealth University; McGill University; Syracuse University; University of Pittsburgh; Memorial Sloan-Kettering Cancer Center; Johns Hopkins University; University of Rochester; University of Miami; York University; University of Missouri; Georgetown University; National Cancer Institute; Wake Forest University; University of Pennsylvania; Dartmouth College; State University of New York; University of Nebraska Medical Center; Kaiser Permanente; University of South Carolina; University of Minnesota; Massachusetts General Hospital; University of Pretoria; Ohio State University; D. Warren Brown Family Foundation; Leukemia and Lymphoma Society","keywords":"Fludarabine; Rituximab; Medicine; Internal medicine; Chronic lymphocytic leukemia; Oncology; Leukemia; Surgery; Chemotherapy; Lymphoma; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002664959,0.0002299987,0.0005719594,0.0005977987,0.0002684726,0.000723746,0.0002682784,0.0003866358,0.000663543],"category_scores_gemma":[0.004264999,0.000190054,0.0007632396,0.0007337225,0.0003239413,0.0004138314,0.0002270025,0.0005005434,0.00008455337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008763829,"about_ca_system_score_gemma":0.0004546749,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001895818,"about_ca_topic_score_gemma":0.005011685,"domain_scores_codex":[0.9989055,0.0004883559,0.0001068025,0.0001337162,0.0002510237,0.0001145021],"domain_scores_gemma":[0.996883,0.001425,0.001072327,0.0002031807,0.0001880661,0.000228464],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.02750106,0.0003909064,0.9215794,0.0001448989,0.002242937,0.0002831542,0.0001876647,0.0004304212,0.00179864,0.00007647478,0.0004934905,0.04487094],"study_design_scores_gemma":[0.001550652,0.007458004,0.984527,0.00003395429,0.001944661,0.001001882,0.00008573104,0.0004535302,0.0007316616,0.00005794704,0.002140371,0.00001466213],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968059,0.00258177,0.00007065729,0.00005250398,0.000005692802,0.00001358143,0.0001352659,0.000002563281,0.0003320455],"genre_scores_gemma":[0.9987483,0.000479346,0.00006742759,0.00007768095,0.00002925578,0.00001909641,0.0004673611,0.000001658169,0.0001097839],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002664959,"threshold_uncertainty_score":0.01409382,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0119435218848345,"score_gpt":0.2820362234149799,"score_spread":0.2700927015301454,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}